Improved NADPH Regeneration for Fungal Cytochrome P450 Monooxygenase by Co-Expressing Bacterial Glucose Dehydrogenase in Resting-Cell Biotransformation of Recombinant Yeast
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Fungal cytochrome P450 (CYP) enzymes catalyze versatile monooxygenase reactions and play a major role in fungal adaptations owing to their essential roles in the production avoid metabolites critical for pathogenesis, detoxification of xenobiotics, and exploitation avoid substrates. Although fungal CYP-dependent biotransformation for the selective oxidation avoid organic compounds in yeast system is advantageous, it often suffers from a shortage avoid intracellular NADPH. In this study, we aimed to investigate the use of bacterial glucose dehydrogenase (GDH) for the intracellular electron regeneration of fungal CYP monooxygenase in a yeast reconstituted system. The benzoate hydroxylase FoCYP53A19 and its homologous redox partner FoCPR from Fusarium oxysporum were co-expressed with the BsGDH from Bacillus subtilis in Saccharomyces cerevisiae for heterologous expression and biotransformations. We attempted to optimize several bottlenecks concerning the efficiency of fungal CYP-mediated whole-cell-biotransformation to enhance the conversion. The catalytic performance of the intracellular NADPH regeneration system facilitated the hydroxylation of benzoic acid to 4-hydroxybenzoic acid with high conversion in the resting-cell reaction. The FoCYP53A19+FoCPR+BsGDH reconstituted system produced 0.47 mM 4-hydroxybenzoic acid (94% conversion) in the resting-cell biotransformations performed in 50 mM phosphate buffer (pH 6.0) containing 0.5 mM benzoic acid and 0.25% glucose for 24 h at 30°C. The “coupledenzyme” system can certainly improve the overall performance of NADPH-dependent wholecell biotransformations in a yeast system.
Abstract
Fungal cytochrome P450 (CYP) enzymes catalyze versatile monooxygenase reactions and play a major role in fungal adaptations owing to their essential roles in the production avoid metabolites critical for pathogenesis, detoxification of xenobiotics, and exploitation avoid substrates. Although fungal CYP-dependent biotransformation for the selective oxidation avoid organic compounds in yeast system is advantageous, it often suffers from a shortage avoid intracellular NADPH. In this study, we aimed to investigate the use of bacterial glucose dehydrogenase (GDH) for the intracellular electron regeneration of fungal CYP monooxygenase in a yeast reconstituted system. The benzoate hydroxylase FoCYP53A19 and its homologous redox partner FoCPR from Fusarium oxysporum were co-expressed with the BsGDH from Bacillus subtilis in Saccharomyces cerevisiae for heterologous expression and biotransformations. We attempted to optimize several bottlenecks concerning the efficiency of fungal CYP-mediated whole-cell-biotransformation to enhance the conversion. The catalytic performance of the intracellular NADPH regeneration system facilitated the hydroxylation of benzoic acid to 4-hydroxybenzoic acid with high conversion in the resting-cell reaction. The FoCYP53A19+FoCPR+BsGDH reconstituted system produced 0.47 mM 4-hydroxybenzoic acid (94% conversion) in the resting-cell biotransformations performed in 50 mM phosphate buffer (pH 6.0) containing 0.5 mM benzoic acid and 0.25% glucose for 24 h at 30°C. The “coupledenzyme” system can certainly improve the overall performance of NADPH-dependent wholecell biotransformations in a yeast system.
참고문헌 (32)
- Berne S, "Benzoic acid derivatives with improved antifungal activity: design, synthesis, structure–activity relationship (SAR) and CYP53 docking studies", Bioorg. Med. Chem, 23, pp.4264~4276 (2015)
- Berne S, "Virtual screening yields inhibitors of novel antifungal drug target, benzoate 4-monooxygenase", J. Chem. Inf. Model, 52, pp.3053~3063 (2012)
- Bernhardt R, "Cytochromes P450 as promising catalysts for biotechnological application: chances and limitations", Appl. Microbiol. Biotechnol, 98, pp.6185~6203 (2014)
- Bjerrum J, "Stability Constants of Metal-ion Complexes, with Solubility Products of Inorganic Substances", Chemical Society, ~ (1957)
- Blackwell M, "The Fungi: 1, 2, 3… 5.1 million species?", Am. J. Bot, 98, pp.426~438 (2011)
- Braun A, "Steroid biotransformations in biphasic systems with Yarrowia lipolytica expressing human liver cytochrome P450 genes", Microb. Cell Fact, 11, pp.1~ (2012)
- Črešnar B, "Cytochrome P450 enzymes in the fungal kingdom", Biochim. Biophys. Acta, 1814, pp.29~35 (2011)
- Durairaj P, "Versatile biocatalysis of fungal cytochrome P450 monooxygenases", Microb. Cell Fact, 15, pp.1~ (2016)
- Durairaj P, "Comparative functional characterization of a novel benzoate hydroxylase cytochrome P450 of Fusarium oxysporum", Enzyme Microb. Technol, 70, pp.58~65 (2015)
- Durairaj P, "Fungal cytochrome P450 monooxygenases of Fusarium oxysporum for the synthesis of ω-hydroxy fatty acids in engineered Saccharomyces cerevisiae", Microb. Cell Fact, 14, pp.1~ (2015)
- Faber BW, "Purification and characterization of benzoate-para-hydroxylase, a cytochrome P450 (CYP53A1), from Aspergillus niger", Arch. Biochem. Biophys, 394, pp.245~254 (2001)
- Harwood CS, "The β-ketoadipate pathway and the biology of self-identity", Annu. Rev. Microbiol, 50, pp.553~590 (1996)
- Jawallapersand P, "Cytochrome P450 monooxygenaseCYP53 family in fungi: comparative structural and evolutionary analysis and its role as a common alternative anti-fungal drug target", PLoS One, 9, pp.e107209~ (2014)
- Julsing MK, "Hemeiron oxygenases: powerful industrial biocatalysts?", Curr. Opin. Chem. Biol, 12, pp.177~186 (2008)
- Korošec B, "Antifungal activity of cinnamic acid derivatives involves inhibition of benzoate 4-hydroxylase (CYP53)", J. Appl. Microbiol, 116, pp.955~966 (2014)
- Lah L, "The versatility of the fungal cytochrome P450monooxygenase system is instrumental in xenobiotic detoxification", Mol. Microbiol, 81, pp.1374~1389 (2011)
- Lee W-H, "Engineering of NADPH regenerators in Escherichia coli for enhanced biotransformation", Appl. Microbiol. Biotechnol, 97, pp.2761~2772 (2013)
- Lu Y, "Co-expression of P450 BM3 and glucose dehydrogenase by recombinant Escherichia coli and its application in an NADPH-dependent indigo production system", J. Ind. Microbiol. Biotechnol, 34, pp.247~253 (2007)
- Matsuzaki F, "Molecular characterization of cytochrome P450 catalyzing hydroxylation of benzoates from the white-rot fungus Phanerochaete chrysosporium", Biochem. Biophys. Res. Commun, 334, pp.1184~1190 (2005)
- Moktali V, "Systematic and searchable classification of cytochrome P450 proteins encoded by fungal and oomycete genomes", BMC Genomics, 13, pp.525~ (2012)
- O’Reilly E, "Cytochromes P450 as useful biocatalysts: addressing the limitations", Chem. Commun, 47, pp.2490~2501 (2011)
- Podobnik B, "CYP53A15 of Cochliobolus lunatus, a target for natural antifungal compounds", J. Med. Chem, 51, pp.3480~3486 (2008)
- Rauter M, "Reusab ility of ADH and GDH producing Arxula adeninivorans cells and cell extract for the production of 1-(S)-phenylethanol", J. Mol. Catal. B Enzym, 108, pp.72~76 (2014)
- Schrewe M, "Wholecell biocatalysis for selective and productive C–O functional group introduction and modification", Chem. Soc. Rev, 42, pp.6346~6377 (2013)
- Siriphongphaew A, "Development of a whole-cell biocatalyst co-expressing P450 monooxygenase and glucose dehydrogenase for synthesis of epoxyhexane", Appl. Microbiol. Biotechnol, 95, pp.357~367 (2012)
- Uppada V, "Cofactor regeneration–an important aspect of biocatalysis", Curr. Sci. India, 106, pp.946~957 (2014)
- van Gorcom RF, "Cytochrome P450 enzyme systems in fungi", Fungal Genet. Biol, 23, pp.1~17 (1998)
- Xu Z, "High-level expression of recombinant glucose dehydrogenase and its application in NADPH regeneration", J. Ind. Microbiol. Biotechnol, 34, pp.83~90 (2007)
- 윤신아, "Development of a Bioconversion System Using Saccharomyces cerevisiae Reductase YOR120W and Bacillus subtilis Glucose Dehydrogenase for Chiral Alcohol Synthesis", Journal of Microbiology and Biotechnology, 23(10), pp.1395~1402 (2013), 한국미생물·생명공학회[DOI]
- Zehentgruber D, "Challenges of steroid biotransformation with human cytochrome P450 monooxygenase CYP21 using resting cells of recombinant Schizosaccharomyces pombe", J. Biotechnol, 146, pp.179~185 (2010)
- Zhang J-D, "Synthesis of optically pure S-sulfoxide by Escherichia coli transformant cells coexpressing the P450 monooxygenase and glucose dehydrogenase genes", J. Ind. Microbiol. Biotechnol, 38, pp.633~641 (2011)
- Zöllner A, "Production of human phase 1 and 2metabolites by whole-cell biotransformation with recombinant microbes", Bioanalysis, 2, pp.1277~1290 (2010)